已收盤 02-06 16:00:00 美东时间
+3.260
+5.51%
JP Morgan analyst Kenneth Worthington maintains StepStone Group (NASDAQ:STEP) with a Overweight and raises the price target from $84 to $91.
02-07 04:59
华盛资讯2月6日讯,StepStone Group, Inc. Class A公布2025财年Q4业绩,公司Q4营收5.87亿美元,同比增长73.0%,归母净利润亏损1.23亿美元,同比亏损缩窄35.7%。
02-06 14:48
华盛资讯2月6日讯,StepStone Group, Inc. Class A公布2025财年Q4业绩,公司Q4营收5.87亿美元,同比增长73.0%,归母净利润亏损1.23亿美元,同比亏损缩窄35.7%。
02-06 13:21
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据StepStone业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **收入表现:** - 费用收入达到2.41亿美元,同比增长26% - 扣除追溯费用后,费用收入同比增长32% - 追溯费用仅110万美元,远低于去年同期的970万美元 **盈利能力:** - 费用相关收益(FRE)为8900万美元,同比增长20%,利润率为37% - 核心费用相关收益为8800万美元,同比增长35%,利润率维持在37% - 调整后净收入为8000万美元(每股0.65美元),较去年同期的5300万美元(每股0.44美元)大幅增长 **GAAP vs No
02-06 12:34
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
Evercore ISI Group analyst John Dunn maintains StepStone Group (NASDAQ:STEP) with a Outperform and raises the price target from $68 to $76.
01-22 23:36
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Barclays analyst Benjamin Budish maintains StepStone Group (NASDAQ:STEP) with a Equal-Weight and raises the price target from $69 to $71.
2025-12-13 04:27
Every so often in this business you run across a firm that has quietly built it...
2025-12-12 00:45